Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia [1]

Annals of Hematology

Volumn 86, Issue 8, 2007, Pages 609-611

  Pakakasama, Samart ^a   Kanchanakamhaeng, Kittima ^a   Kajanachumpol, Saowanee ^a   Udomsubpayakul, Umaporn ^a   Sirachainan, Nongnuch ^a   Thithapandha, Amnuay ^a   Hongeng, Suradej ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; FOLIC ACID; GENOMIC DNA; MERCAPTOPURINE; METHOTREXATE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW SUPPRESSION; CHI SQUARE TEST; CHILD; CHILD CARE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DNA EXTRACTION; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FISHER EXACT TEST; FREQUENCY ANALYSIS; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; TYPHLITIS;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; INFANT; MALE; METHOTREXATE; METHYLTRANSFERASES; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 34347395374     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0274-x     Document Type: Letter

References (13)

1. Ulrich CM, Robien K, McLeod HL (2003) Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer 3:912-920
2. Lecomte T, Ferraz JM, Zinzindohoue F et al (2004) Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res 10:5880-5888
3. Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M (2002) Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100:3832-3834
4. National Cancer Institute (1998) Common toxicity criteria, version 2.0. National Cancer Institute, Bethesda, MD
5. Yi P, Pogribny IP, James SJ (2002) Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett 181:209-213
6. Hongeng S, Sasanakul W, Chuansumrit A, Pakakasama S, Chattananon A, Hathirat P (2000) Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Med Pediatr Oncol 35:410-414
7. van Ede AE, Laan RF, Blom HJ et al (2001) The C677T mutation in the methylenetetrahydrofolate reductase gene: A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 44:525-530
8. Shimasaki N, Mori T, Samejima H et al (2006) Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 28:64-68
9. Aplenc R, Thompson J, Han P et al (2005) Methyltetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65:2482-2487
10. Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63:1227-1231
11. Herrlinger KR, Cummings JRF, Barnardo MC, Schwab M, Ahmad T, Jewell DP (2005) The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenetics Genomics 15:705-711
12. Cheok MH, Lugthart S, Evans WE (2006) Pharmacogenomics of acute leukemia. Ann Rev Pharmacol Toxicol 46:317-353
13. Stanulla M, Schaeffeler E, Flohr T et al (2005) Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 23:1485-1489